PharmaCyte Biotech Inc (PMCB)

PharmaCyte Biotech Inc (PMCB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.7M; returns 1 day +1.5%, 1 week +4.4%, 1 year -63.0%.

PharmaCyte Biotech Inc (PMCB) is a clinical-stage biotechnology company developing targeted therapies for cancer and diabetes using its proprietary Cell-in-a-Box drug delivery platform. The technology encapsulates genetically engineered live human cells within protective polymer membranes, enabling localized, sustained release of therapeutic agents while shielding the cells from immune attack.

Groups PMCB belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Oncology
• Pancreatic Cancer
• R&D
• Clinical Stage
• Cancer Therapeutics
• Type 1 Diabetes

PMCB financial model: income statement, cash flow and balance sheet